N ANTHONY COLES Transaction History

Date Transaction Value Shares Traded Form
Oct 24 2016
BUY
Grant, award, or other acquisition
$980,000 $14.0 p/Share
70,000

Also insider at

CERE
Cerevel Therapeutics Holdings, Inc. Healthcare
REGN
REGENERON PHARMACEUTICALS, INC. Healthcare
YMTX
YUMANITY THERAPEUTICS, INC. Healthcare
NAC

N Anthony Coles

Director
Cambridge, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Track Activities on CRSP